Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Oric Pharmaceuticals Inc. buy BiotechBee

Start price
20.01.23 / 50%
Target price
Performance (%)
This prediction is currently active. The prediction for Oric Pharmaceuticals Inc. disappoints with a performance of -22.26%. This prediction currently runs until 30.04.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Oric Pharmaceuticals Inc. 0.417% 0.417%
iShares Core DAX® 0.284% -2.845%
iShares Nasdaq 100 -0.713% 2.453%
iShares Nikkei 225® 0.598% 1.320%
iShares S&P 500 -2.171% -3.350%

According to BiotechBee what are the pros and cons of Oric Pharmaceuticals Inc. for the foreseeable future?

Could be very worthwhile Investment >20% year

Comments by BiotechBee for this prediction

In the thread Oric Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -22.26%
Target price 8.000
Ends at 30.04.25

Buy mit Kursziel 8,0